Infectious disease issues in xenotransplantation

Clinical Microbiology Reviews

Volumn 14, Issue 1, 2001, Pages 1-14

  Boneva, R S ^a   Folks, T M ^a   Chapman, L E ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; HUMAN T CELL LEUKEMIA VIRUS; NONHUMAN; POSTOPERATIVE INFECTION; PRIMATE; RETROVIRUS; REVIEW; SWINE; VIRUS INFECTION; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; CLONING, ORGANISM; COMMUNICABLE DISEASES; HUMANS; IMMUNOSUPPRESSION; INFECTION CONTROL; PRIMATES; RISK FACTORS; SWINE; SWINE DISEASES; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; PRIMATES; RNA VIRUSES; SUIDAE; SUS SCROFA; UNIDENTIFIED RETROVIRUS;

EID: 0035136766     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.1.1-14.2001     Document Type: Review

References (135)

1. An unusual virus in cultures from a human nasopharyngeal carcinoma
2. Identification of a full length cDNA for an endogenous retrovirus of miniature swine
3. The risk of using baboons as transplant donors: Exogenous and endogenous viruses
4. Amplification of simian retroviral sequences from human recipients of baboon liver transplants
5. C-type virus particles in pig kidney cell lines
6. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
7. Uncertainty in xenotransplantation: Individual benefit versus collective risk
8. Baboon-to-human cardiac xenotransplantation in a neonate
9. What went wrong in BSE? From prion disease to public disaster
10. The research-policy continuum. Comparing allo- and xenotransplantation
11. Male fetal progenitor cells persist in maternal blood for as long as 27 years
12. Microbiological hazards related to xenotransplantation of porcine organs into man
13. The research program on transmissible spongiform encephalopathies in Britain with special reference to bovine spongiform encephalopathy
14. Xenotransplantation and the risk of retroviral zoonosis
15. Immunoisolated xenogeneic chromaffin cell therapy for chronic pain. Initial clinical experience
16. Xenotransplantation - State of the art update 1999
17. Fatal cercopithecine herpesvirus 1 (B virus) infection following a mucocutaneous exposure and interim recommendations for worker protection
18. Identification of herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma
19. Probable human infection with a newly described virus in the family Paramixoviridae
20. Review. Etiology and epidemiology of the four corners hantavirus outbreak
21. A new variant of the Simian T-lymphotropic virus type 1 (STLV-IF) in the Sukhumi colony of hamadryas baboons
22. Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys
23. Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus
24. Hepatitis B and transplantation
25. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
26. The Draft U.S. Public Health Service (PHS) guideline on infectious disease issues in xenotransplantation
27. Anthrax
28. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
29. Infectious disease transmission through cell, tissue, and organ transplantation: Reducing the risk through donor selection
30. Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review
31. Sites of simian foamy virus persistence in naturally infected African green monkeys: Latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa
32. Cancer risk associated with simian virus 40 contaminated polio vaccine
33. Xenosis and xenotransplantation: Addressing the infectious risk posed by an emerging technology
34. Infection and xenotransplantation. Developing strategies to minimize risk
35. Human immunodeficiency virus infection due to clotting factor concentrates: Results of the seroconversion surveillance project
36. A unique natural human IgG antibody with anti-alpha-galactosyl specificity
37. Increased antigal activity in diabetic patients transplanted with porcine islet cells
38. Origin of HIV-2 in the chimpanzee Pan troglodytes troglodytes
39. Geographic and molecular epidemiology of primate lymphotropic retroviruses: HTLV-I, HTLV-II, STLV-I, STLV-PP and PTLV-L
40. PCR amplification and DNA sequencing of SRV-2 from archived tumor tissue
41. Polyomaviruses
42. Pig-to-human islet transplantation
43. Classification of Epstein-Barr virus associated post-transplant lymphoproliferative diseases: Implications for understanding their pathogenesis and developing rational treatment strategies
44. Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1
45. Strategies for diagnosis of xenotransplant-associated retroviral infections
46. Highly sensitive and specific polymerase chain reaction assays for detection of baboon and pig cells following xenotransplantation in humans
47. Identification of a human population infected with simian foamy viruses
48. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts
49. Absence of polyomavirus JC in glial brain tumors and glioma-derived cell lines
50. Age and human immunodeficiency virus infection in persons with hemophilia in California
51. Guidelines for the prevention and treatment of B-virus infections in exposed persons
52. Replication of baboon endogenous retrovirus in human cells. Kinetics of DNA synthesis and integration
53. Oncogenesis and poliomyelitis vaccine
54. Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: Evidence of cross-species transmission in the wild
55. Artificial liver: Review and Cedars-Sinai experience
56. Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria
57. Polyomaviruses and human tumors: A brief review of current concepts and interpretations
58. Natural history of endemic type D retrovirus infection and acquired immunodeficiency syndrome in group-housed rhesus monkeys
59. Two sets of human-tropic pig retroviruses
60. Biologic and immunologic properties of porcine type C viruses
61. The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon xenotransplantats
62. Cloning the differences between two complex genomes
63. Screening of baboons as potential liver donors for humans
64. Human T-lymphotropic virus type I infection
65. Expression of pig endogenous retrovirus by primary endothelial cells and infection of human cells
66. Porcine endogenous retrovirus was not transmitted from transplanted endothelial cells to baboons in vivo
67. Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboons
68. Development and validation of a western immunoblot assay for detection of antibodies to porcine endogenous retrovirus
69. Infectivity of endogenous baboon type-C virus-related genes
70. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus
71. Xenotransplant-associated zoonoses. Strategies for prevention
72. Screening donors for xenotransplantation. The potential for xenozoonoses
73. Xenotransplantation: Risks, clinical potential and future prospects
74. C-type particles produced by a permanent cell line from a leukemic pig. II. Physical, chemical and serological characterization of particles
75. Simian T-cell leukemia virus type I infection in captive baboons
76. The public health risk of animal organ and tissue transplantation into humans
77. Chimerism in transplantation and in spontaneously occurring autoimmune disease
78. Transfer of porcine endogenous retrovirus across hollow fiber membranes: Significance to a bioartificial liver
79. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: No impact on cancer incidence rates 1960-1993
80. Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue
81. Transplantation of discordant xenografts: A challenge revisited
82. Isohemagglutinins and xenoreactive antibodies: Members of a distinct family of natural antibodies
83. Infections in solid-organ transplant recipients
84. Our retroviral heritage
85. Infection of human cells by endogenous retrovirus of pigs
86. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys
87. Outbreak of Nipah virus infection among abattoir workers in Singapore: Description of a new infectious disease - Malaysia and Singapore
88. An apparently new virus (family Paramyxoviridae) infectious for pigs, humans and fruit bats
89. New directions for organ transplantation
90. An array of murine leukemia virus related elements is transmitted and expressed in a primate recipient of a retroviral gene transfer
91. Xenografts raise questions about cancer virus transfer to humans
92. Renal heterotransplantation
93. Survival of porcine pancreatic islet tissue transplanted to a diabetic patient: Findings by ultrastructural immunochemistry
94. Detection and identification of previously unrecognized microbial pathogens
95. Enzymatic remodeling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis
96. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts
97. Transplantation of embryonic porcine mesencephalic tissue in patients with Parkinson's disease
98. Simian foamy virus isolated from accidentally infected human individual
99. Human exposure to SV40: Review and comment
100. Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: Relation to primate retroviruses
101. Pandemic influenza: A zoonosis?
102. HIV transmission by organ and tissue transplantation
103. Fatal human disease from vervet monkeys
104. Renal heterotransplantation from baboon to man: Experience with 6 cases
105. Baboon-to-human liver transplantation
106. Regulation of immune reactivity and tolerance by antigen migration and localization: With particular reference to allo- and xenotransplantation
107. No clear answers on safety of pigs as tissue donor source
108. C-type particles produced by a permanent cell line from a leukemic pig. I. Origin and properties of the host cells and some evidence for the occurrence of C-type-like particles
109. Contamination of poliovirus vaccine with simian virus 40 (1955-1963) and subsequent cancer rates
110. Some characteristics of a porcine retrovirus from a cell line derived from swine malignant lymphomas
111. Molecular cloning of unintegrated closed circular DNA of porcine retrovirus
112. Polymerase chain reaction for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts
113. Host range and interference studies of three classes of pig endogenous retrovirus
114. Initial genetic characterization of the 1918 "Spanish" influenza virus
115. The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation
116. Type C viruses from baboons: Isolation from normal cell cultures
117. Characterization of a type C virus released from the porcine cell line PK (15)
118. Baboon endogenous virus evolution and ecology
119. Kuru and "new variant" CJD
120. Biology of B virus in macaque and human hosts: A review
121. Transgenic pigs and virus adaptation
122. Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission
123. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells
124. Medical consequences of antibiotic use in agriculture
125. The universal ancestor